OLMA
Price
$4.46
Change
+$0.25 (+5.94%)
Updated
Jun 6 closing price
Capitalization
287.71M
64 days until earnings call
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
884.73K
60 days until earnings call
Interact to see
Advertisement

OLMA vs SQZB

Header iconOLMA vs SQZB Comparison
Open Charts OLMA vs SQZBBanner chart's image
Olema Pharmaceuticals
Price$4.46
Change+$0.25 (+5.94%)
Volume$995.79K
Capitalization287.71M
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$59.56K
Capitalization884.73K
OLMA vs SQZB Comparison Chart
Loading...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OLMA vs. SQZB commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OLMA is a Hold and SQZB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (OLMA: $4.96 vs. SQZB: $0.03)
Brand notoriety: OLMA and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OLMA: 53% vs. SQZB: 3%
Market capitalization -- OLMA: $287.71M vs. SQZB: $884.73K
OLMA [@Biotechnology] is valued at $287.71M. SQZB’s [@Biotechnology] market capitalization is $884.73K. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OLMA’s FA Score shows that 1 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • OLMA’s FA Score: 1 green, 4 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, both OLMA and SQZB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OLMA’s TA Score shows that 5 TA indicator(s) are bullish.

  • OLMA’s TA Score: 5 bullish, 3 bearish.

Price Growth

OLMA (@Biotechnology) experienced а -1.00% price change this week, while SQZB (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

OLMA is expected to report earnings on Aug 12, 2025.

SQZB is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OLMA($288M) has a higher market cap than SQZB($885K). SQZB YTD gains are higher at: -6.667 vs. OLMA (-14.923).
OLMASQZBOLMA / SQZB
Capitalization288M885K32,542%
EBITDA-141.86MN/A-
Gain YTD-14.923-6.667224%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash434MN/A-
Total Debt1.43MN/A-
TECHNICAL ANALYSIS
Technical Analysis
OLMA
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
Bullish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
-3.69%
RCKT - OLMA
51%
Loosely correlated
+6.44%
DNLI - OLMA
49%
Loosely correlated
-1.29%
IDYA - OLMA
48%
Loosely correlated
+0.72%
CGON - OLMA
48%
Loosely correlated
-0.94%
CRSP - OLMA
47%
Loosely correlated
-0.92%
More

SQZB and

Correlation & Price change

A.I.dvisor tells us that SQZB and ATHA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SQZB and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
ATHA - SQZB
26%
Poorly correlated
+0.31%
OLMA - SQZB
13%
Poorly correlated
-3.69%
BRTX - SQZB
9%
Poorly correlated
-1.84%
BVAXF - SQZB
8%
Poorly correlated
+9.15%
ENTBF - SQZB
5%
Poorly correlated
N/A
More